Monthly Prescribing Reference

Toujeo Max SoloStar Gets FDA Approval for Patients With Diabetes

Sanofi announced that the Food and Drug Administration (FDA) has approved Toujeo (insulin glargine 300 Units/mL) Max SoloStar, a long-acting insulin pen that holds 900 Units of Toujeo and provides up ...
FierceBiotech

Sanofi Receives FDA Approval of Once-Daily Basal Insulin Toujeo®

PARIS, Feb. 25, 2015 /PRNewswire-USNewswire/ -- Sanofi announced today that the U.S. Food and Drug Administration (FDA) approved Toujeo® (insulin glargine [rDNA origin] injection, 300 U/mL), a ...
Monthly Prescribing Reference

Once-Daily Insulin in Prefilled Pen Gets FDA Nod

New Insulin in Prefilled Pen Gets FDA Nod Sanofi announced that the Food and Drug Administration (FDA) has approved once-daily Toujeo (insulin glargine [rDNA origin]) injection 300 U/mL to improve ...
News Medical

Sanofi announces FDA approval of Toujeo insulin to improve glycemic control in people with diabetes

Sanofi announced today that the U.S. Food and Drug Administration (FDA) approved Toujeo ® (insulin glargine [rDNA origin] injection, 300 U/mL), a once-daily long-acting basal insulin, to improve ...
PharmaTimes

FDA gives green light to Sanofi Lantus follow-up Toujeo

Sanofi has been boosted by the news that the US Food and Drug Administration has approved Toujeo, the follow-up to its diabetes blockbuster Lantus. Sanofi has been boosted by the news that the US Food ...
PharmaTimes

Real world data back Sanofi’s Toujeo for type I diabetes

Sanofi has unveiled real-world data from the UK showing the efficacy of its long-acting basal insulin analogue Toujeo in treating patients in type I diabetes. Sanofi has unveiled real-world data from ...
Seeking Alpha

FDA OKs Sanofi's long-acting insulin pen Toujeo Max SoloStar

The FDA approves Sanofi's (NASDAQ:SNY) Toujeo (insulin glargine 300 Units/mL) Max SoloStar. The product holds 900 Units of Toujeo and can deliver up to 160 Units in a single injection. The company ...
Medscape

EU Gives Green Light to Toujeo, a Better Insulin Glargine?

The European Union has given the nod to a new formulation of insulin glargine (Toujeo, Sanofi), which is a higher-strength insulin (300 units/mL) than the existing insulin glargine product on the ...
FiercePharma

Toujeo® Receives Positive Opinion from the European Regulatory Authorities

Paris, France - February 27, 2015 - Sanofi announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion ...
Bloomberg L.P.

Sanofi’s Toujeo Drug Shows Promise as Lantus Successor

Sanofi’s experimental insulin Toujeo controlled diabetes better than the company’s best-selling Lantus in three tests that suggest the new drug may help buoy sales when the older one loses patent ...